基本资料 投资组合 财务数据 基金公告
港股创新药ETF广发(513120) |
净值：
1.2822
|
日增长率：
1.42%
|
累计净值：1.2822 | 2026-11-10 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| 02269 | 药明生物 | 50,180,000.00 | 2,414,382,649.38 | 10.35 |
| 06160 | 百济神州 | 11,680,500.00 | 2,260,035,042.17 | 9.69 |
| 01801 | 信达生物 | 26,009,500.00 | 2,189,169,702.77 | 9.39 |
| 02359 | 药明康德 | 11,335,200.00 | 2,093,973,985.04 | 8.98 |
| 01093 | 石药集团 | 186,072,000.00 | 1,608,460,217.24 | 6.90 |
| 09926 | 康方生物 | 16,978,000.00 | 1,584,221,492.41 | 6.79 |
| 01548 | 金斯瑞生物-一千 | 34,780,000.00 | 1,339,333,323.34 | 5.74 |
| 03692 | 翰森制药 | 41,922,000.00 | 1,270,329,918.37 | 5.45 |
| 01177 | 中国生物制药 | 258,349,000.00 | 1,266,317,826.39 | 5.43 |
| 02268 | 药明合联 | 11,495,500.00 | 809,173,303.02 | 3.47 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2026-09-30 | 99.04 | - | 1.74 | 23,319,275,140.87 |
| 2026-06-30 | 99.03 | - | 3.89 | 24,038,711,677.20 |
| 2026-03-31 | 99.07 | - | 2.02 | 24,847,688,808.16 |
| 2025-12-31 | 98.70 | - | 2.03 | 23,403,437,149.00 |
| 2025-09-30 | 98.66 | - | 2.13 | 24,888,807,707.82 |
微信公众号
证券之星APP
